Abstract

In healthy subjects, we recently demonstrated that during acute administration of GLP‐1, cardiac output increased significantly, whereas renal blood flow remained constant. We therefore hypothesize that GLP‐1 induces vasodilation in other organs, for example, adipose tissue, skeletal muscle, and/or splanchnic tissues. Nine healthy men were examined twice in random order during a 2‐hour infusion of either GLP‐1 (1.5 pmol kg−1 min−1) or saline. Cardiac output was continuously estimated noninvasively concomitantly with measurement of intra‐arterial blood pressure. Subcutaneous, abdominal adipose tissue blood flow (ATBF) was measured by the 133Xenon clearance technique. Leg and splanchnic blood flow were measured by Fick's Principle, using indocyanine green as indicator. In the GLP‐1 study, cardiac output increased significantly together with a significant increase in arterial pulse pressure and heart rate compared with the saline study. Subcutaneous, abdominal ATBF and leg blood flow increased significantly during the GLP‐1 infusion compared with saline, whereas splanchnic blood flow response did not differ between the studies. We conclude that in healthy subjects, GLP‐1 increases cardiac output acutely due to a GLP‐1‐induced vasodilation in adipose tissue and skeletal muscle together with an increase in cardiac work.

Highlights

  • We recently reported substantial acute effects of physiologically increased plasma levels of GLP-1 on cardiovascular hemodynamics in humans, using continuous measurements (Asmar et al 2015, 2016a)

  • In healthy individuals (Asmar et al 2015) and patients with type 2 diabetes (Asmar et al 2016a), we demonstrated a GLP-1-induced increase in heart rate, possibly due to direct effects of GLP-1 on the heart (Pyke et al 2014)

  • We demonstrate that GLP-1 elicits an increase in subcutaneous, abdominal adipose tissue blood flow (ATBF) during an acute administration of GLP-1

Read more

Summary

Introduction

We recently reported substantial acute effects of physiologically increased plasma levels of GLP-1 on cardiovascular hemodynamics in humans, using continuous (invasive and noninvasive) measurements (Asmar et al 2015, 2016a). In healthy individuals (Asmar et al 2015) and patients with type 2 diabetes (Asmar et al 2016a), we demonstrated a GLP-1-induced increase in heart rate, possibly due to direct effects of GLP-1 on the heart (Pyke et al 2014). GLP-1 increased cardiac output in healthy subjects (~18%, 1.2 Æ 0.1 L/min) but not in patients with type 2 diabetes. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society.

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call